These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26240292)

  • 1. Detecting Plasma Tumor DNA in Early-Stage Breast Cancer-Letter.
    Kodahl AR; Pallisgaard N; Jylling AM; Cold S; Knoop AS; Ditzel HJ
    Clin Cancer Res; 2015 Aug; 21(15):3569. PubMed ID: 26240292
    [No Abstract]   [Full Text] [Related]  

  • 2. Detecting Plasma Tumor DNA in Early-Stage Breast Cancer--Reply.
    Beaver JA; Park BH
    Clin Cancer Res; 2015 Aug; 21(15):3570. PubMed ID: 26240293
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimal residual disease in breast cancer: in blood veritas.
    Siravegna G; Bardelli A
    Clin Cancer Res; 2014 May; 20(10):2505-7. PubMed ID: 24658155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
    Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P
    Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
    Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
    Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.
    Rykova EY; Laktionov PP; Skvortsova TE; Starikov AV; Kuznetsova NP; Vlassov VV
    Ann N Y Acad Sci; 2004 Jun; 1022():217-20. PubMed ID: 15251963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
    Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
    Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer.
    Wang Q; Larson PS; Schlechter BL; Zahid N; Finnemore E; de las Morenas A; Blanchard RA; Rosenberg CL
    Int J Cancer; 2003 Oct; 106(6):923-9. PubMed ID: 12918071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
    Wu X; Tanaka H
    Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
    Shao ZM; Wu J; Shen ZZ; Nguyen M
    Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite alterations plasma DNA of primary breast cancer patients.
    Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
    Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cell free DNA in breast oncology.
    Canzoniero JV; Park BH
    Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
    Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
    PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood].
    Rykova EIu; Skvortsova TE; Hoffmann AL; Tamkovich SN; Starikov AV; Bryzgunova OE; Permiakova VI; Warnecke JM; Sczakiel G; Vlasov VV; Laktionov PP
    Biomed Khim; 2008; 54(1):94-103. PubMed ID: 18421914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating free DNA: a new surrogate marker for minimal residual disease?
    Fehm T; Banys M
    Breast Cancer Res Treat; 2011 Nov; 130(1):119-22. PubMed ID: 21327462
    [No Abstract]   [Full Text] [Related]  

  • 19. Does molecular monitoring matter in early-stage breast cancer?
    Sundaresan TK; Haber DA
    Sci Transl Med; 2015 Aug; 7(302):302fs35. PubMed ID: 26311727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
    Belic J; Koch M; Ulz P; Auer M; Gerhalter T; Mohan S; Fischereder K; Petru E; Bauernhofer T; Geigl JB; Speicher MR; Heitzer E
    Adv Exp Med Biol; 2016; 924():147-155. PubMed ID: 27753036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.